Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
IGM Biosciences, Inc.
IGM Biosciences, Inc.
OHSU Knight Cancer Institute
National Institute of Allergy and Infectious Diseases (NIAID)
University of Miami